Successful Management of Peripartum Cardiomyopathy in a 29-year-old Woman

Qanita Iqbal, Zurriyani Zurriyani, Lyra Febrianda

Abstract


Introduction: Peripartum Cardiomyopathy (PPCM), a rare yet life-threatening disease, is defined as an idiopathic cardiomyopathy due to left ventricle (LV) systolic dysfunction without any other cause of heart failure. It occurs in the last month of pregnancy or within 5 months after delivery. The diagnosis is commonly delayed due to resemblance of symptoms with the normal pregnancy or postpartum condition. Here, we highlight the importance of recognizing the early symptoms of PPCM.

Case Presentation: A 29-year-old woman was admitted to emergency department with manifestation of heart failure that had lasted for 2 days. There was a history of delivery about 40 days ago. Physical examination showed sign of shock, regular heart rhythm, rhonchi in bilateral basal of lung, mild hepatomegaly, and generalized edema. Laboratory result demonstrated elevation of liver transaminase levels. Chest X-Ray had feature of cardiomegaly while echocardiography finding showed reduction of LV systolic function, global hypokinetic, dilatation of LV, and minimal pericardial effusion. The patient was managed with optimal preload reduction. Afterwards, aldosterone antagonist, anticoagulant, and bromocriptine were given immediately. Clinical symptoms improved and the patient was discharged on the 4th day of hospitalization with the planning of echocardiography re-evaluation regularly.  

Discussion: PPCM mortality rate ranges widely which is about 7%-50%. Common misdiagnosed or delayed PPCM would be potentially lethal for mother and the baby. Thus, multidisciplinary patient care is highly recommended aiming for heart failure symptoms treatment prior to targeted therapies.

Conclusion: Early recognition and management should be addressed properly to achieve favorable outcome.


Keywords


Heart failure, Peripartum Cardiomyopathy, Pregnancy, Postpartum

References


Arany, Z., & Elkayam, U. (2016). Peripartum cardiomyopathy. Circulation, 133(14), 1397–1409. https://doi.org/10.1161/CIRCULATIONAHA.115.020491

Arrigo, M., Blet, A., & Mebazaa Alexandre. (2017). Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD. European Heart Journal (2017) 0, 1–3, 0, 1–3.

Bauersachs, J., König, T., van der Meer, P., Petrie, M. C., Hilfiker-Kleiner, D., Mbakwem, A., Hamdan, R., Jackson, A. M., Forsyth, P., de Boer, R. A., Mueller, C., Lyon, A. R., Lund, L. H., Piepoli, M. F., Heymans, S., Chioncel, O., Anker, S. D., Ponikowski, P., Seferovic, P. M.,Sliwa, K. (2019). Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure, 21(7), 827–843. https://doi.org/10.1002/ejhf.1493

Bhattacharyya A, B. S. S. P. K. B. (2012). Peripartum Cardiomyopathy A Review. In Tex Heart Inst J (Vol. 39, Issue 1).

Dash, D., Mody, R., Reno Malan, S., Ahmed, N., Mody, B., & Artículo, I. (2022). Peripartum cardiomyopathy: A 2022 update Miocardiopatía periparto: una actualización de 2022. IBEROAMERICAN JOURNAL OF MEDICINE, 02(2), 104–112. https://doi.org/10.53986/ibjm.2022.0016

Davis, M. B., Arany, Z., McNamara, D. M., Goland, S., & Elkayam, U. (2020). Peripartum Cardiomyopathy: JACC State-of-the-Art Review. In Journal of the American College of Cardiology (Vol. 75, Issue 2, pp. 207–221). Elsevier Inc. https://doi.org/10.1016/j.jacc.2019.11.014

Douglass, E. J., & Blauwet, L. A. (2021). Peripartum Cardiomyopathy. In Cardiology Clinics (Vol. 39, Issue 1, pp. 119–142). W.B. Saunders. https://doi.org/10.1016/j.ccl.2020.09.008

Hoes, M. F., Arany, Z., Bauersachs, J., Hilfiker-Kleiner, D., Petrie, M. C., Sliwa, K., & van der Meer, P. (2022). Pathophysiology and risk factors of peripartum cardiomyopathy. In Nature Reviews Cardiology (Vol. 19, Issue 8, pp. 555–565). Nature Research. https://doi.org/10.1038/s41569-021-00664-8

Honigberg, M. C., & Givertz, M. M. (2019). Peripartum cardiomyopathy. In BMJ (Online) (Vol. 364). BMJ Publishing Group. https://doi.org/10.1136/bmj.k5287

Johnson-Coyle, L., Jensen, L., & Sobey, A. (2012). Peripartum cardiomyopathy: Review and practice guidelines. American Journal of Critical Care, 21(2), 89–99. https://doi.org/10.4037/ajcc2012163

Karafiatova, L., Lazarova, M., & Taborsky, M. (2017). Peripartum cardiomyopathy – A case report and concise review. In Cor et Vasa (Vol. 59, Issue 3, pp. e272–e276). Elsevier Science B.V. https://doi.org/10.1016/j.crvasa.2016.12.013

Karaye, K. M. (2016). Clinical characteristics and prognosis of peripartum cardiomyopathy. Department of public health and clinical medicine, Umeå University.

Kulkarni, A., Squire, G., Hogrefe, K., & Waseem Osman, M. (2021). Peripartum cardiomyopathy. The Obstetrician & Gynaecologist, 23(4), 278–289. https://doi.org/10.1111/tog.12770

Kumari, A., Singh, S., Singh, S., & Chaturvedi, M. (2012). Peripartum cardiomyopathy: A review of three case reports. Journal of SAFOG, 4(3), 164–166. https://doi.org/10.5005/jp-journals-10006-1204

Okeke, T., Ezenyeaku, C., & Ikeako, L. (2013). Peripartum Cardiomyopathy. Annals of Medical and Health Sciences Research, 3(3), 313. https://doi.org/10.4103/2141-9248.117925

Sitio, M., Tri Tjahjono, C., Martini, H., & Kurnianingsih, N. (2021). Peripartum Cardiomyopathy (PPCM): How to Diagnose and Deal with? Heart Science Journal, 2(1), 46–49. https://doi.org/10.21776/ub.hsj.2021.002.01.08

Sliwa, K., Bauersachs, J., Arany, Z., Spracklen, T. F., & Hilfiker-Kleiner, D. (2021). Peripartum cardiomyopathy: From genetics to management. In European Heart Journal (Vol. 42, Issue 32, pp. 3094–3102). Oxford University Press. https://doi.org/10.1093/eurheartj/ehab458

Sreelatha, S., Shilpashree, M., Ashwini Rani, M., & Ramaiah, R. (2013). 20 Medica Innovatica June 2013 Volume 2 Issue 1 Case Report Peripartum Cardiomyopathy-A Case Report 1 2 2 3.

Sudarman, B. M. (2018). Peripartum Cardiomyopathy (PPCM) : Case Report and Review of Literatures. Jurnal Kedokteran Dan Kesehatan Indonesia, 9(1), 60–67. https://doi.org/10.20885/jkki.vol9.iss1.art11

Taryètba André, A. S., Théodore, B., Jean, E. B., Kadari, C., Andrés Miguel, L., André K, S., & Patrice, Z. (2020). Prognosis of peripartum cardiomyopathy in sub-Saharan Africa (Burkina Faso South-West PPCM register). Journal of Cardiology and Cardiovascular Medicine, 5(2), 109–113. https://doi.org/10.29328/journal.jccm.1001096

Wang, M. (2009). Peripartum Cardiomyopathy: Case Report (Vol. 13, Issue 4). http://xnet.kp.org/


Full Text: PDF

DOI: 10.24815/jks.v24i2.37476

Refbacks

  • There are currently no refbacks.